Companies: 10,795·Total market cap: $144.5T
Apollomics, Inc.

Apollomics, Inc.

APLMNASDAQHealthcare● Active
$14.00
+$0.00(+0.00%)
Market Cap$15446872
P/E Ratio—
52W High$42.12
52W Low$3.659
SEC Filings

Apollomics, Inc. (APLM) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001944885 · APLM · NASDAQ · as of Jun 8, 2026

Filing snapshot

151
Total Filings
EFFECT
Latest Form
2026-06-02
Most Recent
2021
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001944885 · Updated hourly · Not investment advice

Latest Annual Report

20-F · Annual Report (Foreign Issuer)FY
Filed Date
2026-04-24
Fiscal Year End
Apr 24, 2026
Accession No.
0001193125-26-177357
Primary Document
aplm-20251231.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001944885 · Accession 0001193125-26-177357

Latest Key Filings

10-QQuarterly Report

No recent filings

8-KCurrent Report

No recent filings

Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
EFFECTEFFECT
EFFECT
2026-06-02
View
F-3/AF-3/A
F-3/A
2026-05-15
View
6-KCurrent Report (Foreign Issuer)
6-K
2026-04-27
View
20-FAnnual Report (Foreign Issuer)
20-F
2026-04-24
View
3/AInitial Statement of Beneficial Ownership (Amended)
3/A
2026-04-17
View
3/AInitial Statement of Beneficial Ownership (Amended)
3/A
2026-04-14
View
3/AInitial Statement of Beneficial Ownership (Amended)
3/A
2026-04-14
View
3/AInitial Statement of Beneficial Ownership (Amended)
3/A
2026-04-14
View
3/AInitial Statement of Beneficial Ownership (Amended)
3/A
2026-04-14
View
3/AInitial Statement of Beneficial Ownership (Amended)
3/A
2026-04-14
View
3/AInitial Statement of Beneficial Ownership (Amended)
3/A
2026-04-14
View
3/AInitial Statement of Beneficial Ownership (Amended)
3/A
2026-04-14
View
SCHEDULE 13DSCHEDULE 13D
SCHEDULE 13D
2026-04-08
View
SCHEDULE 13D/ASCHEDULE 13D/A
SCHEDULE 13D/A
2026-04-06
View
6-KCurrent Report (Foreign Issuer)
6-K
2026-04-01
View
Showing 1–15 of 145 filingsForm 4 / 144 hidden· 151 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001944885  |  Exchange: NASDAQ · Healthcare

Apollomics, Inc. (NASDAQ: APLM) has submitted 151 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2021. As a Healthcare sector company with CIK 0001944885, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Apollomics, Inc.'s most comprehensive regulatory disclosure. The most recent Apollomics, Inc. 10-K was filed on 2026-04-24 for fiscal year ending 2026. Historical APLM 10-K annual reports are available from 2022 through 2026.

Investors researching Apollomics, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Healthcare
ANL SEC Filings →THAR SEC Filings →LPTX SEC Filings →ATHA SEC Filings →BLRX SEC Filings →ADAP SEC Filings →LNAI SEC Filings →ICU SEC Filings →
→ APLM Financials→ APLM Earnings→ APLM Insider Trades

Frequently Asked Questions

APLM SEC Filings · 8 questions

Apollomics, Inc. (APLM) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 151 filings and access original documents at no cost. Apollomics, Inc.'s CIK is 0001944885.

APLM SEC filingsApollomics, Inc. SEC documentsfind APLM 10-K